
    
      Twenty eight (twenty six study subjects + two alternate subjects)healthy male and/or female
      subjects participated in an open label, two-period, two-sequence, two- treatment,single dose,
      two-way crossover study with at least 14 days washout between doses conducted under fed
      conditions.
    
  